Metabolism-based inactivation of penile nitric oxide synthase activity by guanabenz.

Metabolism-based inactivation of penile nitric oxide synthase activity by guanabenz.
复制标题

DOI:
--
复制
发表时间:
1998-05
期刊:
Drug metabolism and disposition: the biological fate of chemicals
影响因子:
--
通讯作者:
M. Nakatsuka;K. Nakatsuka;Y. Osawa
M. Nakatsuka;K. Nakatsuka;Y. Osawa
中科院分区:
其他
文献类型:
--
作者:
M. Nakatsuka;K. Nakatsuka;Y. Osawa

文献摘要

相似文献

胍那苄(Wytensin)在体外和体内显示出降低一氧化氮合酶(NOS)活性。在使用阴茎组织胞质组分的体外研究中,发现灭活取决于NADPH、时间和胍那苄浓度。精氨酸的L-异构体(而非D-异构体)可保护细胞免于失活,表明活性位点定向事件。失活的动力学可以描述为初始可逆复合物(Ki)和伪一级失活常数(kinact)分别为38.5 μ M和0.179 min-1的表观解离常数。在体内研究中,胍那苄以剂量和时间依赖性方式抑制阴茎胞质NOS活性。用胍那苄(5 mg/kg/天)治疗大鼠4天,导致阴茎胞质组分的NOS活性降低约一半,同时免疫可检测NOS蛋白量减少。治疗4天,剂量为0。5 mg/kg/天剂量组显示出类似的活动减少,而0.05 mg/kg/天剂量组显示无影响。由于NO调节的过程众多,NOS的失活是与药物相关的各种生物学效应中要考虑的潜在机制。
Guanabenz (Wytensin) was shown to inactivate nitric oxide synthase (NOS) activity in vitro and in vivo. In in vitro studies with the use of a cytosolic fraction from penile tissue, the inactivation was found to depend on NADPH, time, and the concentration of guanabenz. The L-, but not the D-, isomer of arginine could protect from the inactivation, suggesting an active site-directed event. The kinetics of inactivation could be described by an apparent dissociation constant for the initial reversible complex (Ki) and a pseudo first-order inactivation constant (kinact) of 38.5 microM and 0.179 min-1, respectively. In in vivo studies, guanabenz was shown to inhibit penile cytosolic NOS activity in a dose- and time-dependent manner. Treatment of rats with guanabenz (5 mg/kg/day) for 4 days caused a decrease of approximately one-half in the NOS activity of the penile cytosolic fraction with a concomitant loss in the amount of immunodetectable NOS protein. Treatment for 4 days at a dose of 0. 5 mg/kg/day showed a similar decrease in activity, whereas a dose of 0.05 mg/kg/day showed no effects. Due to the multitude of processes that are regulated by NO, the inactivation of NOS is a potential mechanism to be considered in a variety of biological effects associated with drugs.